AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
LETROZOLE in Zimbabwe
5 products registered with MCAZ — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| FEMPRO TABLET, COATED; ORAL | 2023/9.5.2/6463 | CIPLA LTD | active | 11 Aug 2028 |
| LETRASAN TABLET, COATED; ORAL | 2017/9.1/5343 | KEY ONCOLOGICS (PYT) LTD | active | 31 Dec 2027 |
| LETROZOLE TABLET, COATED; ORAL | 2021/9.5.2/6106 | NOVARTIS SOUTH AFRICA (PTY) LTD | active | 31 Dec 2027 |
| FEMARA TABLET, COATED; ORAL | 2015/9.5.2/5110 | NOVARTIS PHARMA SERVICES AG | active | 31 Dec 2027 |
| LETERO TABLET, COATED; ORAL | 2015/9.5.2/5043 | HETERO LABS LTD | active | 31 Dec 2027 |
LETROZOLE — MCAZ Registration Details
MCAZ (Zimbabwe) has 5 registered products containing LETROZOLE, of which 5 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track LETROZOLE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.